ADVERTISEMENT

October 2021

Pharmacy Today logo
Volume 27, Issue 10

Archives   Download TOC  

Current Issue

October 2021 cover

Download  

ADVERTISEMENT
 

Practice & Trends

Walmart–Novo Nordisk insulin offers deep discounts to select few
Practice & Trends

Diabetes

Walmart–Novo Nordisk insulin offers deep discounts to select few

Early last summer, Walmart announced the launch of a new privatebrand, cash-pay analog insulin, made by drug manufacturer Novo Nordisk. Sold under Walmart’s private ReliOn label, vials go for $72.88 each and FlexPens for $85.88 each. Walmart calculates that the products will save customers between 58% and 75% of the cash price for branded analog insulin products, which translates to savings of up to $101 per branded vial or $251 per package of branded FlexPens.

Sonya Collins

RSS
RSS

Drugs & Diseases

Common foot disorders
Drugs & Diseases

OTCs Today

Common foot disorders

Up to 75% of Americans will experience foot health problems at some point in their lives. Women are 4 times more likely to experience foot problems than men.

Daniel L. Krinsky, RPh, MS

Drugs & Diseases

Insulin

FDA approves first interchangeable biosimilar insulin

In July 2021, FDA approved the first interchangeable biosimilar insulin product (Semglee–Viatris/Biocon Biologics, insulin glargineyfgn), which can be substituted for its reference product (Lantus–Sanofi Aventis, insulin glargine) at the pharmacy level, depending on state pharmacy laws.

Maria G. Tanzi, PharmD

RSS

Health Systems

IDSA and ACG release C. difficile guidelines
Health Systems

C.diff

IDSA and ACG release C. difficile guidelines

Two new sets of guidelines on the management of Clostridioides difficile are now available—one from the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA), and the other from the American College of Gastroenterology (ACG).

Maria G. Tanzi, PharmD

RSS

CPE

Moving toward health equity: A journey
CPE

CPE

Moving toward health equity: A journey

Breonna Taylor, George Floyd, and countless other victims of racist violence have prompted more conversations focused on societal discrimination and racial injustice, but police violence is not the only form racial injustice takes in the United States. The global COVID-19 pandemic has also shone a light on and underscored the inadequacies and inequities of the United States health care system, as well as the negative consequences of those inequities disproportionately experienced by communities of color.

Juan Rodriguez, BSPS; Adrienne Simmons, PharmD, MS, BCPS, AAHIVP; Arya Amirfar, PharmD, MPH, FAPhA

RSS

In this Issue

ADVERTISEMENT